This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Polymerase chain reaction (PCR) tests for bacterial meningitis and meningococcal disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Polymerase chain reaction (PCR) tests for bacterial meningitis and meningococcal disease:

  • perform whole blood real-time PCR testing (EDTA sample) for N meningitidis to confirm a diagnosis of meningococcal disease
  • the PCR blood sample should be taken as soon as possible because early samples are more likely to be positive
  • use PCR testing of blood samples from other hospital laboratories if available, to avoid repeating the test
  • be aware that a negative blood PCR test result for N meningitidis does not rule out meningococcal disease
  • submit CSF to the laboratory to hold for PCR testing for N meningitidis and S pneumoniae, but only perform the PCR testing if the CSF culture is negative
  • be aware that CSF samples taken up to 96 hours after admission to hospital may give useful results. Skin samples and throat swabs for meningococcal disease

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.